Susquehanna International Group
EMMA

Susquehanna International Group’s Emmaus Life Sciences, Inc. Common Stock EMMA Stock Holding History

Susquehanna International Group’s Portfolio EMMA Stock Details EMMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-7,584
Closed -$72K – 10495
2018
Q3 		$72K Buy
7,584
+2,332
+44% +$23.1K ﹤0.01% 8733
2018
Q2 		$57K Buy
+5,252
New +$69.4K ﹤0.01% 9238

Other funds holding EMMA

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
FFA
First Foundation Advisors Irvine, California $2.48B AUM 18.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Susquehanna International Group's EMMA Position: Q4 2018 in Review

Susquehanna International Group sold out of Emmaus Life Sciences, Inc. Common Stock (EMMA) in Q4 2018, closing a stake of 7,584 shares — an estimated $72K sold.

Susquehanna International Group first reported a position in EMMA in Q2 2018 and held it in 2 quarters. The position peaked at $72K in Q3 2018. 11 funds tracked by Wall St. Rank hold EMMA as of Q4 2018.

  • Susquehanna International Group reported no remaining Emmaus Life Sciences, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
  • Susquehanna International Group sold 7,584 Emmaus Life Sciences, Inc. Common Stock shares in Q4 2018, an estimated $72K.
  • Susquehanna International Group first reported a position in Emmaus Life Sciences, Inc. Common Stock in Q2 2018 and held it in 2 quarters.
  • Susquehanna International Group's Emmaus Life Sciences, Inc. Common Stock position peaked at $72K in Q3 2018.
  • 11 funds tracked by Wall St. Rank held Emmaus Life Sciences, Inc. Common Stock as of Q4 2018.

Based on Susquehanna International Group's 13F filing for Q4 2018, filed 14 Feb 2019.